Pharmacological analysis of 5‐hydroxytryptamine effects on electrically stimulated human isolated urinary bladder
Authors:
Open Access
- 1 November 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 104 (3) , 719-725
Abstract
5‐Hydroxytryptamine (5‐HT) is able to potentiate the contractions induced by electrical field stimulation of pieces of human isolated urinary bladder. On the basis of available selective 5‐HT agonists and antagonists, we have further investigated the receptors involved and their site of action. 5‐HT produced a concentration‐dependent increase of the contractile response to electrical field stimulation from 0.1 nm to μm. At higher concentrations (up to 100 μm) the effect decreased. These activities were mimicked by a variety of 5‐HT agonists, for which the following rank order of potency was found: 5‐HT > α‐methyl 5‐HT > 5‐methoxytryptamine > 5‐carboxamidotryptamine > 2‐methyl 5‐HT ≫ GR 43175. In addition the gastro‐prokinetics agents metoclopramide, cisapride and the 5‐HT3 antagonist ICS 205–930 behaved as 5‐HT agonists, their EC50 values being 2.3, 0.3, and 0.5 (μm) respectively. The 5‐HT potentiating effect was resistant to antagonism by ondansetron (1 μm) and cyanopindolol (1 μm), selective 5‐HT3 and 5‐HT1A/1B antagonists respectively. The 5‐HT2 antagonists ketanserin (1 μm), spiperone (1 μm) and methysergide (1 μm) also showed a weak inhibitory activity. Methiothepin (0.1–1 μm) antagonized only the inhibitory effect of 5‐HT. Metoclopramide (0.1–1 μm), cisapride (0.01–0.1 μm) and ICS 205–930 (0.3–3 μm) all produced a rightward displacement of the 5‐HT response curve with concomitant reduction of the maximum response. The pA2 values calculated were 7.4, 8.5 and 7.0 respectively. The antagonism of metoclopramide was receptor specific and was not apparently related to interactions with dopaminergic activity since domperidone showed no antagonism of 5‐HT, and metoclopramide, itself, did not antagonize the potentiating effect of prostaglandin F2α. The receptor involved in the potentiating effect of 5‐HT may be located prejunctionally because 5‐HT did not potentiate responses to acetylcholine (ACh) or electrical field stimulation with the parameters of direct muscle excitation. Also, since the 5‐HT potentiating effect was blocked by atropine, it may be attributed to a release of ACh. This study suggests that in the human urinary bladder 5‐HT causes two opposite effects on the contractile response to electrical field stimulation. A potentiating effect at low concentrations due to an interaction with an atypical receptor, different from the classical 5‐HT1, 5‐HT2 or 5‐HT3 subtypes and an inhibitory effect at greater concentrations probably due to an interaction with 5‐HT1‐like receptors. The possibility that this atypical receptor possesses some characteristics of those found in other isolated preparations like guinea‐pig ileum, rat oesophagus and mouse embryo colliculi neurones is discussed.Keywords
This publication has 19 references indexed in Scilit:
- A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.Molecular Pharmacology, 1988
- GR43175, a selective agonist for the 5‐HT1‐like receptor in dog isolated saphenous veinBritish Journal of Pharmacology, 1988
- Activation of a myenteric 5-hydroxytryptamine-like receptor by metoclopramideJournal of Pharmacy and Pharmacology, 1987
- On the nature of the receptor mediating the action of 5-hydroxytryptamine in potentiating responses of the mouse urinary bladder strip to electrical stimulationNaunyn-Schmiedeberg's Archives of Pharmacology, 1986
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985
- Ketanserin—a novel antihypertensive drug?Journal of Pharmacy and Pharmacology, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959
- TWO KINDS OF TRYPTAMINE RECEPTORBritish Journal of Pharmacology and Chemotherapy, 1957